Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal

Metabolism: Clinical and Experimental

Volumn 59, Issue 2, 2010, Pages 195-199

  Lin, Shih Yi ^a,b   Huang, Shu Chuan ^a   Sheu, Wayne Huey Herng ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; LEVOTHYROXINE; RADIOACTIVE IODINE; THYROGLOBULIN; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CLINICAL ARTICLE; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; PRIORITY JOURNAL; THYROID CANCER; THYROID HORMONE METABOLISM; THYROID SCINTISCANNING; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADIPONECTIN; ADULT; BODY COMPOSITION; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 74049129834     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.06.032     Document Type: Article

References (31)

1. Kim B.W. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid 18 (2008) 141-144
2. Douyon L., and Schteingart D.E. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin N Am 31 (2002) 173-189
3. Krotkiewski M. Thyroid hormones in the pathogenesis and treatment of obesity. Eur J Pharmacol 440 (2002) 85-98
4. al-Adsani H., Hoffer L.J., and Silva J.E. Resting energy expenditure is sensitive to small dose change in patients with chronic thyroid hormone replacement. J Clin Endocrinol Metab 82 (1997) 1118-1125
5. Hoogwerf B.J., and Nuttall F.Q. Long-term regulation in the treated hyperthyroid and hypothyroid subjects. Am J Med 76 (1984) 963-970
6. Knudsen N., Laurberg P., Rasmussen L.P., Bulow I., Perrild H., Ovesen L., et al. Small difference in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 90 (2005) 4019-4025
7. Kim B.J., Kim T.Y., Kim H.K., Park J.Y., Lee K.U., Shong K.Y., et al. Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol 70 (2009) 152-160
8. Kadowaki T., and Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev 26 (2005) 439-451
9. Shklyaev S., Aslandini G., Tennant N., Prima V., Kohlbrenner E., Kroutov V., et al. Sustained peripheral expression of transgenic adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci USA 100 (2003) 14217-14222
10. Fruebis J., Tsao T.S., Javorschi S., Ebbets-Reed D., Erickson M.R., Yen F.T., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA 98 (2001) 2005-2010
11. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP activated protein kinase. Nat Med 8 (2002) 1288-1295
12. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
13. Fernandez-Real J.M., Lopez-Bermejo A., Casamitjhan R., and Ricart W. Novel interactions of adiponectin with the endocrine system and inflammatory parameters. J Clin Endocrinol Metab 88 (2003) 2714-2718
14. Malyszko J., Malyszko J., Wolczynski S., and Mysliwiec M. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement: are they related?. Nephrol Dial Transplant 21 (2006) 145-152
15. Iacobellis G., Ribaudo M.C., Zappaterreno A., Iannucci C.V., and Leonetti F. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol 62 (2005) 487-491
16. Cooper D.S., Doherty G.M., Huagen B.R., Kloos R.T., Lee S.L., Mandel S.J., et al. Management guidelines with patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16 (2006) 1-33
17. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
18. Liel Y. Preparation for radioactive iodine administration in differentiated thyroid cancer patients. Clin Endocrinol 57 (2002) 523-527
19. Serhal D.I., Nasrallah M.P., and Arafah B.M. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer. J Clin Endocrinol Metab 89 (2004) 3285-3289
20. Bianco A.C., Salvatore D., Gereben B., Gerry M.J., and Larsen P.R. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine deiodinases. Endocr Rev 23 (2002) 38-89
21. Dimitriadis G., Mitrou P., Lambadiari V., Boutati E., Maratou E., Panagiotakos D.B., et al. Insulin action in adipose tissue and muscle in hypothyroidism. J Clin Endocrino Metab 91 (2006) 4930-4937
22. Iglesias P., Fidalgo P.A., Condoceo R., and Diez J.J. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol 59 (2003) 621-629
23. Botella-Carretero J.I., Alvarez-Blasco F., Sancho J., and Escobar-Morreale H.F. Effects of thyroid hormones on serum levels of adipocytokines as studied in patients with differentiated thyroid carcinoma during thyroxine withdrawal. Thyroid 16 (2006) 397-402
24. Altinova A.E., Toruner F.B., Akturk M., Bukan N., Cakir N., Ayvaz G., et al. Adiponectin levels and cardiovascular risk factors in hypothyroidism and hyperthyroidism. Clin Endocrinol 65 (2006) 530-535
25. Santini F., Pinchera A., Marsili A., Ceccarini G., Castagna M.G., Valeriano R., et al. Lean body mass is a major determinant of levothyroxine dosage in the treatment of thyroid diseases. J Clin Endocrinol Metab 90 (2005) 124-127
26. Leonard J.L., and Koerle J. Intracellular pathways of iodothyronines metabolism. In: Braverman L.E., and Utiger R.D. (Eds). Werner and Ingbar's the thyroid. A fundamental and clinical text (2000), Linppicott Williams, Wilkins, Philidelphia 136-173
27. Roos A., Bakker S.J.L., Links T.P., Gans R.O.B., and Wolffenbuttel B.H.R. Thyroid function is associated with components of the metabolic syndrome in the euthyroid subjects. J Clin Endocrinol Metab 92 (2007) 491-496
28. Grozovsky R., Ribich S., Rosene M.L., Mulcahey M.A., Hung S.A., Patti M.E., et al. Type 2 deiodinase expression is induced by PPAR-γ agonists in skeletal myocytes. Endocrinology 150 (2009) 1976-1983
29. Iglesias P., and Diez J.J. Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 40 (2007) 61-70
30. Hsieh C.J., Wang P.W., Wang S.T., Liu R.T., Tung S.C., Chien W.Y., et al. Serum leptin concentrations of patients with sequential thyroid function changes. Clin Endocrinol 57 (2002) 29-34
31. Flier J.S. What's in a name? In search of leptin's physiological role. J Clin Endocrinol Metab 83 (1998) 1407-1413